These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 14678249)

  • 1. Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology.
    Bengtsson SH; Gulluyan LM; Dusting GJ; Drummond GR
    Clin Exp Pharmacol Physiol; 2003 Nov; 30(11):849-54. PubMed ID: 14678249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of oxidative stress in the endothelium and vascular wall.
    Jiang F; Drummond GR; Dusting GJ
    Endothelium; 2004; 11(2):79-88. PubMed ID: 15370067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells.
    Chamseddine AH; Miller FJ
    Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2284-9. PubMed ID: 12855428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.
    Touyz RM; Chen X; Tabet F; Yao G; He G; Quinn MT; Pagano PJ; Schiffrin EL
    Circ Res; 2002 Jun; 90(11):1205-13. PubMed ID: 12065324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nox family of NADPH oxidases: friend or foe of the vascular system?
    Takac I; Schröder K; Brandes RP
    Curr Hypertens Rep; 2012 Feb; 14(1):70-8. PubMed ID: 22071588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms for suppressing NADPH oxidase in the vascular wall.
    Dusting GJ; Selemidis S; Jiang F
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():97-103. PubMed ID: 15962105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall.
    Görlach A; Brandes RP; Nguyen K; Amidi M; Dehghani F; Busse R
    Circ Res; 2000 Jul; 87(1):26-32. PubMed ID: 10884368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence.
    Tsai IC; Pan ZC; Cheng HP; Liu CH; Lin BT; Jiang MJ
    J Mol Cell Cardiol; 2016 Sep; 98():18-27. PubMed ID: 27381955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADPH oxidases in vascular pathology.
    Konior A; Schramm A; Czesnikiewicz-Guzik M; Guzik TJ
    Antioxid Redox Signal; 2014 Jun; 20(17):2794-814. PubMed ID: 24180474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.
    Frey RS; Ushio-Fukai M; Malik AB
    Antioxid Redox Signal; 2009 Apr; 11(4):791-810. PubMed ID: 18783313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide production and expression of nox family proteins in human atherosclerosis.
    Sorescu D; Weiss D; Lassègue B; Clempus RE; Szöcs K; Sorescu GP; Valppu L; Quinn MT; Lambeth JD; Vega JD; Taylor WR; Griendling KK
    Circulation; 2002 Mar; 105(12):1429-35. PubMed ID: 11914250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.
    Drummond GR; Selemidis S; Griendling KK; Sobey CG
    Nat Rev Drug Discov; 2011 Jun; 10(6):453-71. PubMed ID: 21629295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel isoforms of NADPH-oxidase in cerebral vascular control.
    Miller AA; Drummond GR; Sobey CG
    Pharmacol Ther; 2006 Sep; 111(3):928-48. PubMed ID: 16616784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.
    Rivera J; Sobey CG; Walduck AK; Drummond GR
    Redox Rep; 2010; 15(2):50-63. PubMed ID: 20500986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle.
    Ellmark SH; Dusting GJ; Fui MN; Guzzo-Pernell N; Drummond GR
    Cardiovasc Res; 2005 Feb; 65(2):495-504. PubMed ID: 15639489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular NAD(P)H oxidases: specific features, expression, and regulation.
    Lassègue B; Clempus RE
    Am J Physiol Regul Integr Comp Physiol; 2003 Aug; 285(2):R277-97. PubMed ID: 12855411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo.
    Wingler K; Wünsch S; Kreutz R; Rothermund L; Paul M; Schmidt HH
    Free Radic Biol Med; 2001 Dec; 31(11):1456-64. PubMed ID: 11728818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial NADPH oxidases: which NOX to target in vascular disease?
    Drummond GR; Sobey CG
    Trends Endocrinol Metab; 2014 Sep; 25(9):452-63. PubMed ID: 25066192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5.
    Cheng G; Cao Z; Xu X; van Meir EG; Lambeth JD
    Gene; 2001 May; 269(1-2):131-40. PubMed ID: 11376945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension.
    Jung O; Schreiber JG; Geiger H; Pedrazzini T; Busse R; Brandes RP
    Circulation; 2004 Apr; 109(14):1795-801. PubMed ID: 15037533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.